ATE85215T1 - Antivirales therapeutikum. - Google Patents

Antivirales therapeutikum.

Info

Publication number
ATE85215T1
ATE85215T1 AT88901147T AT88901147T ATE85215T1 AT E85215 T1 ATE85215 T1 AT E85215T1 AT 88901147 T AT88901147 T AT 88901147T AT 88901147 T AT88901147 T AT 88901147T AT E85215 T1 ATE85215 T1 AT E85215T1
Authority
AT
Austria
Prior art keywords
liposome
protein
antiviral therapeutic
envelope
engulf
Prior art date
Application number
AT88901147T
Other languages
English (en)
Inventor
Slobodan Tepic
Original Assignee
Experimentelle Chirurgie Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Experimentelle Chirurgie Lab filed Critical Experimentelle Chirurgie Lab
Application granted granted Critical
Publication of ATE85215T1 publication Critical patent/ATE85215T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88901147T 1987-12-19 1987-12-19 Antivirales therapeutikum. ATE85215T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP1987/000806 WO1989005633A1 (en) 1987-12-19 1987-12-19 Anti-viral therapeutic composition
EP88901147A EP0346343B1 (de) 1987-12-19 1987-12-19 Antivirales therapeutikum

Publications (1)

Publication Number Publication Date
ATE85215T1 true ATE85215T1 (de) 1993-02-15

Family

ID=8165225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88901147T ATE85215T1 (de) 1987-12-19 1987-12-19 Antivirales therapeutikum.

Country Status (5)

Country Link
EP (1) EP0346343B1 (de)
JP (1) JPH02502633A (de)
AT (1) ATE85215T1 (de)
DE (1) DE3784080T2 (de)
WO (1) WO1989005633A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897873A (en) * 1984-04-12 1999-04-27 The Liposome Company, Inc. Affinity associated vaccine
US5026557A (en) * 1987-09-09 1991-06-25 The Liposome Company, Inc. Adjuvant composition
EP0432693A1 (de) * 1989-12-11 1991-06-19 Sumitomo Chemical Company, Limited Für virusinfizierte Zellen cytotoxische Liposomen
US9408890B2 (en) 2013-01-22 2016-08-09 The Charles Stark Draper Laboratory, Inc. Multivalent liposome formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
DE2942780A1 (de) * 1979-10-23 1981-05-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Eukaryotische zellen, eukaryotische protoplasten und vielzellige eukaryotische lebende organismen mit einem gehalt an durch lipidvesikel eingebrachter dna, verfahren zu ihrer herstellung von gen-produkten, zur immunisierung und zur behebung genetisch bedingter defekte
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
US4652257A (en) * 1985-03-21 1987-03-24 The United States Of America As Represented By The Secretary Of The Navy Magnetically-localizable, polymerized lipid vesicles and method of disrupting same
US4663161A (en) * 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
FR2592893A1 (fr) * 1986-01-15 1987-07-17 Pasteur Institut Population de lymphocytes t4 specifiques du virus lav, leur procede d'obtention et leur application a la production de ce virus.

Also Published As

Publication number Publication date
EP0346343A1 (de) 1989-12-20
JPH02502633A (ja) 1990-08-23
DE3784080T2 (de) 1993-05-27
WO1989005633A1 (en) 1989-06-29
DE3784080D1 (en) 1993-03-18
EP0346343B1 (de) 1993-02-03

Similar Documents

Publication Publication Date Title
AU3332089A (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU617088B2 (en) Peptides involved in the pathogenesis of hiv infection
NZ217645A (en) Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations
BR8703379A (pt) Disposicao combinada de controle de mao e pe
KR870700638A (ko) 임균의 주로 철-조절된 단백질과 이의 백신으로서의 용도
PT84849A (pt) Enhanced expression of human interleukin-2 in mammalian cells
DE3688937D1 (de) Herstellung optisch aktiver aryloxypropanolamine und arylaethanolamine.
AU4638085A (en) Therepautic preparations fortreatment of certain viral and other diseases and the preparation of the same
ATE85215T1 (de) Antivirales therapeutikum.
IT8619072A0 (it) Miglioramenti relativi a preparati virali di isolamento e al loro uso.
NO171242C (no) Fremgangsmaate for fremstilling av hudpleiepreparater med keratolytisk og antiinflammatorisk virkning
IT1214598B (it) Uso terapeutico della fosfocreatina.
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
DK141090A (da) Fremstilling af human prourokinase
FR2615737B1 (fr) Preparation et utilisation d'interferon-gamma
NZ224393A (en) Recombinant hiv envelope proteins and uses thereof
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
ES542349A0 (es) "procedimiento para separar y obtener d-alfa-tocoferol"
ATE336588T1 (de) In-vitro verpackung von adeno-assozierten virus dns
ZA893085B (en) Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
SE8705060D0 (sv) Antiforkylningssats, antiforkylningspreparat och anvendning derav
NO912099D0 (no) Ekspresjon av hiv-proteiner i drosophilia-celler.
FR2622108B1 (fr) Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
AU7873587A (en) Assay to detect the presence of live hepatitis virus in vitro
ATE98679T1 (de) Herstellung des hblv-virus in der hsb-2 zelllinie.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee